LABCORP HOLDINGS INC. Tax Withholding Paid on Stock Awards
LABCORP HOLDINGS INC. (LH) reported Tax Withholding Paid on Stock Awards of $46.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $6.30M, a 80.00% increase year-over-year.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $39.80M, a 56.08% increase year-over-year.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $1.30M, a 83.12% decline year-over-year.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $1.60M, a 77.78% increase year-over-year.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $31.90M, a 31.25% decline from fiscal 2024.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $46.40M, a 16.58% increase from fiscal 2023.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $39.80M, a 21.34% decline from fiscal 2022.
- LABCORP HOLDINGS INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $50.60M.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $46.10M 10-Q · filed 2026-08-05 | $47.40M derived: sum of 3 quarters · filed 2026-08-05 | $49.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $39.80M 10-Q · filed 2026-05-04 | $41.10M derived: sum of 2 quarters · filed 2026-05-04 | $42.70M derived: sum of 3 quarters · filed 2026-05-04 | $46.20M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.90M derived: sum of 2 quarters · filed 2026-02-24 | $6.40M derived: sum of 3 quarters · filed 2026-08-05 | $31.90M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $5.10M derived: sum of 2 quarters · filed 2026-08-05 | $30.60M 10-Q · filed 2025-10-31 | $38.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $29.00M 10-Q · filed 2026-08-05 | $36.70M derived: sum of 3 quarters · filed 2026-08-05 | $37.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $25.50M 10-Q · filed 2026-05-04 | $33.20M derived: sum of 2 quarters · filed 2026-05-04 | $34.10M derived: sum of 3 quarters · filed 2026-05-04 | $57.20M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.60M derived: sum of 2 quarters · filed 2026-02-24 | $31.70M derived: sum of 3 quarters · filed 2026-02-24 | $46.40M 10-K · filed 2026-02-24 |
| 2024-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $24.00M derived: sum of 2 quarters · filed 2025-10-31 | $38.70M 10-Q · filed 2025-10-31 | $38.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $37.80M 10-Q · filed 2025-08-01 | $38.00M derived: sum of 3 quarters · filed 2026-02-24 | $38.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $14.70M 10-Q · filed 2025-04-29 | $14.90M derived: sum of 2 quarters · filed 2026-02-24 | $15.80M derived: sum of 3 quarters · filed 2026-02-24 | $34.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.10M derived: sum of 2 quarters · filed 2026-02-24 | $19.30M derived: sum of 3 quarters · filed 2026-02-24 | $39.80M 10-K · filed 2026-02-24 |
| 2023-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $19.10M derived: sum of 2 quarters · filed 2024-10-29 | $39.60M 10-Q · filed 2024-10-29 | $45.60M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $18.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $38.70M 10-Q · filed 2024-08-02 | $44.70M derived: sum of 3 quarters · filed 2025-02-25 | $51.90M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $20.50M 10-Q · filed 2024-04-30 | $26.50M derived: sum of 2 quarters · filed 2025-02-25 | $33.70M derived: sum of 3 quarters · filed 2025-02-25 | $43.80M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $13.20M derived: sum of 2 quarters · filed 2025-02-25 | $23.30M derived: sum of 3 quarters · filed 2025-02-25 | $50.60M 10-K · filed 2025-02-25 |
| 2022-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $17.30M derived: sum of 2 quarters · filed 2023-10-30 | $44.60M 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $37.40M 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $27.30M 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $16.30M derived: sum of 2 quarters · filed 2022-11-01 | $44.40M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $14.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $43.00M 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | $28.10M 10-Q · filed 2022-04-29 | |||
| 2020-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $10.00M derived: sum of 2 quarters · filed 2021-11-02 | $32.00M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $31.50M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $22.00M 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $21.00M derived: sum of 2 quarters · filed 2020-10-29 | $40.40M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $20.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $40.10M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $19.40M 10-Q · filed 2020-05-08 | |||
| 2018-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $21.20M derived: sum of 2 quarters · filed 2019-10-31 | $46.20M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $20.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $45.10M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $25.00M 10-Q · filed 2019-05-03 | |||
| 2017-09-30 | $46.50M 10-Q · filed 2018-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |